JP2013520278A - 高血糖及び低血糖傾向を通知する分析物試験方法及びシステム - Google Patents
高血糖及び低血糖傾向を通知する分析物試験方法及びシステム Download PDFInfo
- Publication number
- JP2013520278A JP2013520278A JP2012554979A JP2012554979A JP2013520278A JP 2013520278 A JP2013520278 A JP 2013520278A JP 2012554979 A JP2012554979 A JP 2012554979A JP 2012554979 A JP2012554979 A JP 2012554979A JP 2013520278 A JP2013520278 A JP 2013520278A
- Authority
- JP
- Japan
- Prior art keywords
- blood glucose
- threshold
- user
- microprocessor
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 136
- 210000004369 blood Anatomy 0.000 title claims abstract description 136
- 238000012360 testing method Methods 0.000 title claims description 38
- 239000012491 analyte Substances 0.000 title description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 177
- 239000008103 glucose Substances 0.000 claims abstract description 177
- 238000000034 method Methods 0.000 claims abstract description 50
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 39
- 238000005259 measurement Methods 0.000 claims description 119
- 235000012054 meals Nutrition 0.000 claims description 23
- 238000011156 evaluation Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 4
- 210000002784 stomach Anatomy 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 92
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 49
- 229940125396 insulin Drugs 0.000 description 26
- 102000004877 Insulin Human genes 0.000 description 24
- 108090001061 Insulin Proteins 0.000 description 24
- 230000006870 function Effects 0.000 description 18
- 230000008569 process Effects 0.000 description 15
- 238000007726 management method Methods 0.000 description 13
- 238000013523 data management Methods 0.000 description 10
- 150000001720 carbohydrates Chemical class 0.000 description 9
- 235000014633 carbohydrates Nutrition 0.000 description 9
- 229940127560 insulin pen Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 238000004364 calculation method Methods 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 229940124597 therapeutic agent Drugs 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 4
- 238000012384 transportation and delivery Methods 0.000 description 4
- 230000008859 change Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 238000012913 prioritisation Methods 0.000 description 3
- 230000000630 rising effect Effects 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 description 2
- 208000013016 Hypoglycemia Diseases 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 2
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001019 normoglycemic effect Effects 0.000 description 2
- -1 trend alert 212 Proteins 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 1
- 101100406385 Caenorhabditis elegans ola-1 gene Proteins 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 108010089308 Insulin Detemir Proteins 0.000 description 1
- 108010057186 Insulin Glargine Proteins 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical group [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 150000002303 glucose derivatives Chemical class 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 229940038661 humalog Drugs 0.000 description 1
- WNRQPCUGRUFHED-DETKDSODSA-N humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229940060975 lantus Drugs 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 229940102988 levemir Drugs 0.000 description 1
- UGOZVNFCFYTPAZ-IOXYNQHNSA-N levemir Chemical compound CCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=2N=CNC=2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=2C=CC=CC=2)C(C)C)CSSC[C@@H]2NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(C)C)CSSC[C@H](NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC2=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CC(N)=O)C(O)=O)CC1=CC=C(O)C=C1 UGOZVNFCFYTPAZ-IOXYNQHNSA-N 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 229940112879 novolog Drugs 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7271—Specific aspects of physiological measurement analysis
- A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/70—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Primary Health Care (AREA)
- Epidemiology (AREA)
- Data Mining & Analysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Databases & Information Systems (AREA)
- Artificial Intelligence (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Emergency Medicine (AREA)
- Optics & Photonics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Physiology (AREA)
- General Business, Economics & Management (AREA)
- Business, Economics & Management (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Abstract
【選択図】図1A
Description
Claims (24)
- ディスプレイ、メモリ、及びユーザーインターフェースボタンに接続されたマイクロプロセッサを有する糖尿病管理ユニットを使用して得られた血糖値における高値又は低値傾向をユーザーに通知する方法であって、該方法が、
前記マイクロプロセッサを使用して、前記ユーザーの複数回の血糖測定を実施する工程と、
前記ユーザーの前記複数回の血糖測定値を前記メモリに保存する工程と、
一日の間の所与の時刻に測定された最新の血糖測定値が、血液1デシリットル当たり約70mgのグルコースである第1の閾値を下回っているか、又は血液1デシリットル当たり約150mgのグルコースである第2の閾値を上回っているかを判定する工程と、
過去の数日を通じた前記最新の血糖測定値の前記所与の時刻前後の約3時間の時間枠内に実施された前記複数の血糖測定のうちの少なくとも1つの血糖測定値が、前記第1の閾値より低いか又は前記第2の閾値より高いかを、マイクロプロセッサを使用して評価する工程と、
前記少なくとも1つの血糖測定値が前記第1の閾値より低い又は前記第2の閾値より高いという前記評価が達成され次第、過去の数日の間の同一時間枠において、前記複数の血糖測定値が、前記第1の閾値より低い血糖測定値の傾向又は前記第2の閾値より高い血糖測定値の傾向を示すことを通知する工程と、
を含む方法。 - ディスプレイ、メモリ、及びユーザーインターフェースボタンに接続されたマイクロプロセッサを有する糖尿病管理ユニットを使用して得られた血糖値における高値又は低値傾向をユーザーに通知する方法であって、該方法が、
前記マイクロプロセッサを使用して、前記ユーザーの複数回の血糖測定を実施する工程と、
前記複数回の血糖測定をメモリに保存する工程と、
一日の間の所与の時刻における最新の血糖測定値が、第1の閾値を下回る又は第2の閾値を上回るかどうかを判定する工程と、
N日間を通じた前記最新の血糖測定値の前記所与の時刻前後のX時間の時間枠内に実施された前記複数回の血糖測定の少なくとも1つの血糖測定値が、前記第1の閾値より低いか又は前記第2の閾値より高いかを、マイクロプロセッサを使用して評価する工程と、
前記評価する工程が達成され次第、前記N日間を通じた同一時間枠において、前記複数回の血糖測定が、低閾値より低い血糖傾向又は第2の閾値より高い血糖傾向を示すことを通知する工程と、を含む方法。 - ディスプレイ、メモリ、及びユーザーインターフェースボタンに接続されたマイクロプロセッサを有する糖尿病管理ユニットを使用して得られた血糖値における高値又は低値傾向をユーザーに通知する方法であって、該方法が、
前記マイクロプロセッサを使用して、前記ユーザーの複数回の血糖測定を実施する工程と、
前記複数回の血糖測定をメモリに保存する工程と、
一日の間の所与の時刻における最新の血糖測定値が第1の閾値を下回るかどうかを判定する工程と、
N日間を通じた前記最新の血糖測定値の前記所与の時刻前後のX時間の時間枠内に実施された前記複数回の血糖測定の少なくとも1つの血糖測定値が、前記第1の閾値より低いかどうかを、マイクロプロセッサを使用して評価する工程と、
前記評価する工程が達成され次第、前記N日間を通じた同一時間枠において、前記複数の血糖測定値が、前記低閾値より低い血糖傾向を示すことを通知する工程と、を含む方法。 - ディスプレイ、メモリ、及びユーザーインターフェースボタンに接続されたマイクロプロセッサを有する糖尿病管理ユニットを使用して得られた血糖値における高値又は低値傾向をユーザーに通知する方法であって、該方法が、
前記マイクロプロセッサを使用して、前記ユーザーの複数回の血糖測定を実施する工程と、
前記複数回の血糖測定をメモリに保存する工程と、
一日の間の所与の時刻における最新の血糖測定値が第2の閾値より高いかどうかを判定する工程と、
N日間を通じた前記最新の血糖測定値の前記所与の時刻前後のX時間の時間枠内に実施された前記複数回の血糖測定の少なくとも1つの血糖測定値が、前記第2の閾値より高いかどうかを、マイクロプロセッサを使用して評価する工程と、
前記評価する工程が達成され次第、前記N日間を通じた同一時間枠において、前記複数回の血糖測定値が、前記第2の閾値より高い血糖傾向を示すことを通知する工程と、を含む方法。 - 前記判定する工程は、前記最新の血糖測定値が(a)食前に行われた測定値又は(b)空腹期間中に行われた測定値であるとフラグ付けされたかどうかを確認することを更に含む、請求項1〜4のいずれか一項に記載の方法。
- 最近のN日間が、約2〜約14の任意の数を含む、請求項5に記載の方法。
- 前記X時間が、約0〜約7時間の間の任意の数を含む、請求項5に記載の方法。
- 前記X時間が、約0〜約3時間の間の任意の数を含む、請求項5に記載の方法。
- 前記第1の閾値が、血液1デシリットル当たり約70mgのグルコースを含む、請求項5に記載の方法。
- 前記第2の閾値が、血液1デシリットル当たり約150mgのグルコースを含む、請求項5に記載の方法。
- 前記通知する工程が、第1の閾値を下回る保存された血糖値の分布を、それぞれの保存された血糖値に対して得られた対応する日付及び時刻を有して表示することを含む、請求項5に記載の方法。
- 前記通知する工程が、第2の閾値を上回る保存された血糖値を、それぞれの保存された血糖値に対して得られた対応する日付及び時刻を有して表示することを含む、請求項5に記載の方法。
- 前記通知する工程が、日付と、時刻と、かかる日付及び時刻における前記第1の閾値を下回る測定血糖値と、を有する表を表示することを含む、請求項5に記載の方法。
- 前記通知する工程が、日付と、時刻と、かかる日付及び時刻における前記第2の閾値を上回る測定血糖値と、を有する表を表示することを含む、請求項5に記載の方法。
- 前記通知する工程が、概して同じ意味を有する異なるメッセージフォーマットを通知することを含む、請求項1〜4のいずれか一項に記載の方法。
- 糖尿病管理システムであって、
グルコース試験ストリップと、
糖尿病管理ユニットと、を含み、該糖尿病管理ユニットが、
前記グルコース試験ストリップを収容するように構成された試験ストリップポートを含むハウジングと、
複数のユーザーインターフェースボタンと、
前記試験ストリップポートに接続されて、前記試験ストリップの上に沈着したユーザーの生理液中の測定されたグルコースの量に関するデータを提供するマイクロプロセッサと、を含み、
該マイクロプロセッサは、メモリ、及びユーザーインターフェースボタンに更に接続され、該マイクロプロセッサが、
(a)前記ユーザーの複数回の血糖測定を実施する、
(b)前記複数回の血糖測定値を保存する、
(c)一日の間の所与の時刻における最新の血糖測定値が、第1の閾値を下回るか又は第2の閾値を上回るかどうかを判定する、
(d)N日間を通じた前記最新の血糖測定値としての、前記所与の時刻前後のX時間の時間枠内に実施された前記複数回の血糖測定の少なくとも1つの血糖測定値が、前記第1の低閾値より低いか又は前記第2の閾値より高いかかどうかを評価する、及び
(e)前記評価する工程が達成され次第、前記N日間を通じた少なくとも2日の同一時間枠内で、前記複数回の血糖測定が、前記低閾値より低い傾向又は前記第2の閾値より高い傾向を示していることを通知する、
ようにプログラムされる、糖尿病管理システム。 - 糖尿病管理システムであって、
グルコース試験ストリップと、
糖尿病管理ユニットと、を含み、該糖尿病管理ユニットが、
前記グルコース試験ストリップを収容するように構成された試験ストリップポートを含むハウジングと、
複数のユーザーインターフェースボタンと、
前記試験ストリップポートに接続されて、前記試験ストリップの上に沈着したユーザーの生理液中の測定されたグルコースの量に関するデータを提供するマイクロプロセッサと、
を含み、該マイクロプロセッサが、メモリ、及びユーザーインターフェースボタンに更に接続され、該マイクロプロセッサが、
(a)前記ユーザーの複数回の血糖測定を実施する、
(b)前記複数回の血糖測定を保存する、
(c)一日の間の所与の時刻における最新の血糖測定値が、第1の閾値を下回るかどうかを判定する、
(d)N日間を通じた前記最新の血糖測定値としての、前記所与の時刻前後のX時間の時間枠内に実施された前記複数回の血糖測定の少なくとも1つの血糖測定値が、前記第1の低閾値より低いかどうかを評価する、及び
(e)前記評価が達成され次第、前記N日間を通じた少なくとも2日の同一時間枠内で、前記複数回の血糖測定値が低閾値より低い傾向を示していることを通知する、
ようにプログラムされる、糖尿病管理システム。 - 糖尿病管理システムにおいて、
グルコース試験ストリップと、
糖尿病管理ユニットと、を含み、該糖尿病管理ユニットが、
前記グルコース試験ストリップを収容するように構成された試験ストリップポートを含むハウジングと、
複数のユーザーインターフェースボタンと、
前記試験ストリップポートに接続されて、前記試験ストリップの上に沈着したユーザーの生理液中の測定されたグルコースの量に関するデータを提供するマイクロプロセッサと、を含み、
該マイクロプロセッサは、メモリ、及びユーザーインターフェースボタンに更に接続され、
(a)前記ユーザーの複数回の血糖測定を実施する、
(b)前記複数回の血糖測定を保存する、
(c)一日の間の所与の時刻における最新の血糖測定値が第2の閾値を上回るかどうかを判定する、
(d)N日間を通じた前記最新の血糖測定値としての、前記所与の時刻前後のX時間の時間枠内に実施された前記複数回の血糖測定の少なくとも1つの血糖測定値が、前記第2の閾値より高いかどうかを判定する、及び
(e)前記評価が達成され次第、前記N日間を通じた少なくとも2日の同一時間枠内で、前記複数回の血糖測定値が低閾値より低い傾向又は第2の閾値より高い傾向を示していることを通知する、ようにプログラムされる、
糖尿病管理システム。 - 前記マイクロプロセッサが、前記最新の血糖測定値が、(a)食前に行われた測定値又は(b)空腹期間といった所与の条件のうちの1つであるとしてフラグ付けされたかどうかを確認するように更にプログラムされる、請求項16〜18のいずれか一項に記載のシステム。
- 前記マイクロプロセッサが、前記所与の条件として、前記最新の血糖測定値が第1の閾値を下回るかどうかを確認するように更にプログラムされる、請求項19に記載のシステム。
- 最近のN日間が、約2〜約14の任意の数を含み、前記X時間が、約0〜約7時間の間の任意の数を含む、請求項19に記載のシステム。
- 前記X時間が、約0〜約3時間の間の任意の数を含む、請求項16に記載のシステム。
- 前記第1の閾値が、血液1デシリットル当たり約70mgのグルコースを含み、前記第2の閾値が、血液1デシリットル当たり約150mgのグルコースを含む、請求項16に記載のシステム。
- 前記マイクロプロセッサが、概して同じ意味を有する異なるメッセージフォーマットを通知するようにプログラムされる、請求項16〜18のいずれか一項に記載のシステム。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30821710P | 2010-02-25 | 2010-02-25 | |
US61/308,217 | 2010-02-25 | ||
US32269710P | 2010-04-09 | 2010-04-09 | |
US61/322,697 | 2010-04-09 | ||
PCT/US2010/040434 WO2011106029A1 (en) | 2010-02-25 | 2010-06-29 | Analyte testing method and system with high and low blood glucose trends notification |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013520278A true JP2013520278A (ja) | 2013-06-06 |
JP5718947B2 JP5718947B2 (ja) | 2015-05-13 |
Family
ID=42935488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012554979A Active JP5718947B2 (ja) | 2010-02-25 | 2010-06-29 | 高血糖及び低血糖傾向を通知する分析物試験方法及びシステム |
Country Status (12)
Country | Link |
---|---|
US (1) | US9563743B2 (ja) |
EP (5) | EP2897068B1 (ja) |
JP (1) | JP5718947B2 (ja) |
KR (1) | KR101722417B1 (ja) |
CN (1) | CN102770868B (ja) |
AU (1) | AU2010346623B2 (ja) |
BR (1) | BR112012021572A2 (ja) |
CA (1) | CA2790910C (ja) |
ES (3) | ES2532146T3 (ja) |
HK (3) | HK1179361A1 (ja) |
RU (1) | RU2553097C2 (ja) |
WO (1) | WO2011106029A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016540564A (ja) * | 2013-12-05 | 2016-12-28 | ライフスキャン・インコーポレイテッドLifescan,Inc. | 糖尿病管理用ボーラス投与フィードバック |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2656074C (en) * | 2006-07-19 | 2018-02-20 | Cross Technology Solutions Ab | Mobile apparatus, method and system for processing blood sugar affecting factors |
US20100095229A1 (en) * | 2008-09-18 | 2010-04-15 | Abbott Diabetes Care, Inc. | Graphical user interface for glucose monitoring system |
US8803688B2 (en) * | 2010-01-07 | 2014-08-12 | Lisa Halff | System and method responsive to an event detected at a glucose monitoring device |
US20110163880A1 (en) * | 2010-01-07 | 2011-07-07 | Lisa Halff | System and method responsive to an alarm event detected at an insulin delivery device |
AU2010346623B2 (en) * | 2010-02-25 | 2015-09-03 | Lifescan Scotland Limited | Analyte testing method and system with high and low blood glucose trends notification |
CN103210311B (zh) * | 2010-12-28 | 2015-03-18 | 泰尔茂株式会社 | 血糖测定装置 |
WO2012108935A1 (en) * | 2011-02-11 | 2012-08-16 | Abbott Diabetes Care Inc. | Sensor-based informatics telemedicine disease management solution |
JP5930823B2 (ja) * | 2011-06-17 | 2016-06-08 | アークレイ株式会社 | 測定装置 |
US20130085349A1 (en) | 2011-06-21 | 2013-04-04 | Yofimeter, Llc | Analyte testing devices |
US9451907B2 (en) | 2011-06-22 | 2016-09-27 | Arkray, Inc. | Measuring apparatus |
KR101367261B1 (ko) * | 2011-11-11 | 2014-03-14 | 주식회사 아이센스 | 시간 동기화 방식이 적용된 무선 통신 모듈을 장착한 혈당 측정기 시스템 |
US8694458B2 (en) * | 2011-12-21 | 2014-04-08 | Teradata Us, Inc. | Making estimations or predictions about databases based on data trends |
KR20140147849A (ko) * | 2012-03-23 | 2014-12-30 | 시락 게엠베하 인터내셔날 | 이전의 생리적 측정치의 분석에 기초한 사용자에 대한 긍정적 강화 메시지 |
US20140074059A1 (en) * | 2012-09-12 | 2014-03-13 | Lifescan, Inc. | Method and system to indicate glycemic impacts of insulin infusion pump commands |
US9592002B2 (en) | 2012-09-21 | 2017-03-14 | Lifescan, Inc. | Method and system to derive multiple glycemic patterns from glucose measurements during time of the day |
US20140129151A1 (en) | 2012-11-07 | 2014-05-08 | Dexcom, Inc. | Systems and methods for managing glycemic variability |
US9826925B2 (en) * | 2012-11-29 | 2017-11-28 | Lifescan, Inc. | Analyte meter with basic and advanced meter preset mode selection based on structured queries |
CN105188532A (zh) * | 2013-03-12 | 2015-12-23 | 豪夫迈·罗氏有限公司 | 用于传输葡萄糖测量的方法、用于在葡萄糖测量的无线传输期间显示状态的方法和手持葡萄糖计 |
US9529503B2 (en) | 2013-06-27 | 2016-12-27 | Lifescan Scotland Limited | Analyte-measurement system recording user menu choices |
US9965587B2 (en) | 2013-07-08 | 2018-05-08 | Roche Diabetes Care, Inc. | Reminder, classification, and pattern identification systems and methods for handheld diabetes management devices |
PL3073918T3 (pl) * | 2013-11-28 | 2023-07-10 | F. Hoffmann-La Roche Ag | Sposób i powiązane ze sposobem urządzenie do analizowania monitorowanych w sposób ciągły fizjologicznych wartości pomiarowych użytkownika, system i produkt w postaci programu komputerowego |
US11035818B2 (en) * | 2014-08-15 | 2021-06-15 | Roche Diabetes Care, Inc. | Blood glucose meter with low cost user interface having programmed graphic indicators |
US20170053084A1 (en) * | 2015-08-21 | 2017-02-23 | Medtronic Minimed, Inc. | Data analytics and reporting of glucose-related information |
KR20170024365A (ko) * | 2015-08-25 | 2017-03-07 | 삼성전자주식회사 | 검사장치 및 그 제어방법 |
CN108283486B (zh) * | 2017-01-09 | 2021-04-09 | 腾讯科技(深圳)有限公司 | 测量数据的处理方法及装置 |
US10818390B1 (en) * | 2017-12-27 | 2020-10-27 | Verily Life Sciences Llc | Pattern discovery in continuous glucose monitoring data |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007317196A (ja) * | 2006-05-24 | 2007-12-06 | Lifescan Inc | 個別化した疾病管理を提供するためのシステム及び方法 |
JP2008501426A (ja) * | 2004-06-03 | 2008-01-24 | メドトロニック ミニメド インコーポレイテッド | 生理的特徴のモニタリングのためのシステム |
JP2008229331A (ja) * | 2007-03-20 | 2008-10-02 | Lifescan Inc | 血糖症管理用の伝達媒体 |
JP2009037588A (ja) * | 2007-03-20 | 2009-02-19 | Lifescan Inc | 糖尿病の管理用プログラム |
US20110205064A1 (en) * | 2010-02-25 | 2011-08-25 | Lifescan Scotland Ltd. | Analyte testing method and system with high and low blood glucose trends notification |
Family Cites Families (130)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4731726A (en) * | 1986-05-19 | 1988-03-15 | Healthware Corporation | Patient-operated glucose monitor and diabetes management system |
US5251126A (en) | 1990-10-29 | 1993-10-05 | Miles Inc. | Diabetes data analysis and interpretation method |
US5956501A (en) | 1997-01-10 | 1999-09-21 | Health Hero Network, Inc. | Disease simulation system and method |
US5307263A (en) * | 1992-11-17 | 1994-04-26 | Raya Systems, Inc. | Modular microprocessor-based health monitoring system |
US6413410B1 (en) * | 1996-06-19 | 2002-07-02 | Lifescan, Inc. | Electrochemical cell |
AUPN363995A0 (en) * | 1995-06-19 | 1995-07-13 | Memtec Limited | Electrochemical cell |
AUPN661995A0 (en) | 1995-11-16 | 1995-12-07 | Memtec America Corporation | Electrochemical cell 2 |
US6863801B2 (en) | 1995-11-16 | 2005-03-08 | Lifescan, Inc. | Electrochemical cell |
WO1998037805A1 (en) | 1997-02-26 | 1998-09-03 | Diasense, Inc. | Individual calibration of blood glucose for supporting noninvasive self-monitoring blood glucose |
AUPO581397A0 (en) | 1997-03-21 | 1997-04-17 | Memtec America Corporation | Sensor connection means |
US6558351B1 (en) * | 1999-06-03 | 2003-05-06 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
US5954643A (en) * | 1997-06-09 | 1999-09-21 | Minimid Inc. | Insertion set for a transcutaneous sensor |
US7267665B2 (en) * | 1999-06-03 | 2007-09-11 | Medtronic Minimed, Inc. | Closed loop system for controlling insulin infusion |
CA2547684C (en) | 1997-12-04 | 2008-02-05 | Roche Diagnostics Corporation | Electrical apparatus |
DE19814219A1 (de) * | 1998-03-31 | 1999-10-07 | Roche Diagnostics Gmbh | Verfahren zur Kontrolle der Insulinmedikation |
US6045513A (en) * | 1998-05-13 | 2000-04-04 | Medtronic, Inc. | Implantable medical device for tracking patient functional status |
DK1144028T3 (da) | 1998-11-30 | 2004-10-18 | Novo Nordisk As | System til at hjælpe en bruger under medicinsk selvbehandling, hvor nævnte selvbehandling omfatter en flerhed af handlinger |
BR9916142A (pt) * | 1998-11-30 | 2001-09-04 | Novo Nordisk As | Método e sistema para ajudar o usuário em um autotratamento médico, o referido autotratamento compreende uma pluralidade de ações |
US6475372B1 (en) | 2000-02-02 | 2002-11-05 | Lifescan, Inc. | Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations |
US7806886B2 (en) * | 1999-06-03 | 2010-10-05 | Medtronic Minimed, Inc. | Apparatus and method for controlling insulin infusion with state variable feedback |
US6193873B1 (en) | 1999-06-15 | 2001-02-27 | Lifescan, Inc. | Sample detection to initiate timing of an electrochemical assay |
US6716577B1 (en) | 2000-02-02 | 2004-04-06 | Lifescan, Inc. | Electrochemical test strip for use in analyte determination |
US7890295B2 (en) * | 2000-02-23 | 2011-02-15 | Medtronic Minimed, Inc. | Real time self-adjusting calibration algorithm |
US6572542B1 (en) * | 2000-03-03 | 2003-06-03 | Medtronic, Inc. | System and method for monitoring and controlling the glycemic state of a patient |
CA2413205A1 (en) * | 2000-06-26 | 2002-01-03 | Boston Medical Technologies, Inc. | Glucose metering system |
WO2002017210A2 (en) | 2000-08-18 | 2002-02-28 | Cygnus, Inc. | Formulation and manipulation of databases of analyte and associated values |
US20020026111A1 (en) * | 2000-08-28 | 2002-02-28 | Neil Ackerman | Methods of monitoring glucose levels in a subject and uses thereof |
WO2002100148A2 (en) * | 2001-06-08 | 2002-12-19 | Novartis Ag | Treatment or prophylaxis of insulin-producing cell graft rejection |
US7179226B2 (en) * | 2001-06-21 | 2007-02-20 | Animas Corporation | System and method for managing diabetes |
US20030208113A1 (en) | 2001-07-18 | 2003-11-06 | Mault James R | Closed loop glycemic index system |
US6544212B2 (en) * | 2001-07-31 | 2003-04-08 | Roche Diagnostics Corporation | Diabetes management system |
US20040162678A1 (en) * | 2001-08-13 | 2004-08-19 | Donald Hetzel | Method of screening for disorders of glucose metabolism |
US20080177154A1 (en) * | 2001-08-13 | 2008-07-24 | Novo Nordisk A/S | Portable Device and Method Of Communicating Medical Data Information |
US6691043B2 (en) * | 2001-08-28 | 2004-02-10 | Maxi-Med, Llc | Bolus calculator |
US20030108976A1 (en) * | 2001-10-09 | 2003-06-12 | Braig James R. | Method and apparatus for improving clinical accuracy of analyte measurements |
US8224663B2 (en) | 2002-05-24 | 2012-07-17 | Becton, Dickinson And Company | System and method for assessment and corrective action based on guidelines |
AU2002346484A1 (en) * | 2001-11-21 | 2003-06-10 | Optiscan Biomedical Corporation | Method and apparatus for improving the accuracy of alternative site analyte concentration measurements |
US6749887B1 (en) | 2001-11-28 | 2004-06-15 | Lifescan, Inc. | Solution drying system |
US7204823B2 (en) * | 2001-12-19 | 2007-04-17 | Medtronic Minimed, Inc. | Medication delivery system and monitor |
US7399277B2 (en) * | 2001-12-27 | 2008-07-15 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US7022072B2 (en) * | 2001-12-27 | 2006-04-04 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US20050027182A1 (en) * | 2001-12-27 | 2005-02-03 | Uzair Siddiqui | System for monitoring physiological characteristics |
US20080255438A1 (en) | 2001-12-27 | 2008-10-16 | Medtronic Minimed, Inc. | System for monitoring physiological characteristics |
US20030212379A1 (en) | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
US6852104B2 (en) * | 2002-02-28 | 2005-02-08 | Smiths Medical Md, Inc. | Programmable insulin pump |
US20030211617A1 (en) | 2002-05-07 | 2003-11-13 | International Business Machines Corporation | Blood glucose meter that reminds the user to test after a hypoglycemic event |
GB2418258B (en) * | 2002-06-05 | 2006-08-23 | Diabetes Diagnostics Inc | Analyte testing device |
US20040068230A1 (en) | 2002-07-24 | 2004-04-08 | Medtronic Minimed, Inc. | System for providing blood glucose measurements to an infusion device |
US8538703B2 (en) * | 2002-08-13 | 2013-09-17 | University Of Virginia Patent Foundation | Method, system, and computer program product for the processing of self-monitoring blood glucose(SMBG)data to enhance diabetic self-management |
US7404796B2 (en) * | 2004-03-01 | 2008-07-29 | Becton Dickinson And Company | System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor |
EP1536729B1 (en) * | 2002-09-11 | 2012-03-21 | Becton Dickinson and Company | Monitoring blood glucose including convenient display of measurement values and averages |
US7291256B2 (en) | 2002-09-12 | 2007-11-06 | Lifescan, Inc. | Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays |
GB2393356B (en) * | 2002-09-18 | 2006-02-01 | E San Ltd | Telemedicine system |
EP1575656B1 (en) * | 2002-10-11 | 2009-06-17 | Becton, Dickinson and Company | Insulin delivery system with sensor |
US20040115754A1 (en) * | 2002-12-11 | 2004-06-17 | Umax Data Systems Inc. | Method for establishing a long-term profile of blood sugar level aiding self-control of the same |
US8718943B2 (en) * | 2003-04-01 | 2014-05-06 | Abbott Diabetes Care Inc. | Method and device for utilizing analyte levels to assist in the treatment of diabetes |
US8845536B2 (en) * | 2003-08-01 | 2014-09-30 | Dexcom, Inc. | Transcutaneous analyte sensor |
KR20060132434A (ko) * | 2003-11-06 | 2006-12-21 | 라이프스캔, 인코포레이티드 | 이벤트 통지 수단을 가지는 약물 전달 펜 |
JP3590054B1 (ja) | 2004-02-26 | 2004-11-17 | 株式会社日立製作所 | 血糖値測定装置 |
DK1718196T3 (da) * | 2004-02-26 | 2009-07-13 | Diabetes Tools Sweden Ab | Metabolisk overvågning, fremgangsmåde og apparat til indikation af en sundhedsrelateret tilstand hos et individ |
WO2005093629A2 (en) | 2004-03-26 | 2005-10-06 | Novo Nordisk A/S | Device for displaying data relevant for a diabetic patient |
TW200608019A (en) | 2004-05-14 | 2006-03-01 | Bayer Healthcare Llc | Methods for performing hematocrit adjustment in glucose assays and devices for same |
US20080045819A1 (en) * | 2004-07-21 | 2008-02-21 | Matsushita Electric Industrial Co., Ltd. | Blood-Sugar Level Management System |
US7344500B2 (en) | 2004-07-27 | 2008-03-18 | Medtronic Minimed, Inc. | Sensing system with auxiliary display |
US7291107B2 (en) | 2004-08-26 | 2007-11-06 | Roche Diagnostics Operations, Inc. | Insulin bolus recommendation system |
US20070010950A1 (en) * | 2004-12-03 | 2007-01-11 | Abensour Daniel S | Method to determine the degree and stability of blood glucose control in patients with diabetes mellitus via the creation and continuous update of new statistical indicators in blood glucose monitors or free standing computers |
CA2590319A1 (en) | 2004-12-17 | 2006-06-22 | Bayer Healthcare Llc | Analyte test device having a trend-indicating display |
WO2006066583A1 (en) | 2004-12-23 | 2006-06-29 | Novo Nordisk A/S | Method and device for enhanced determination of patterns in data related to at least one physiological condition of a user |
ITBO20050002A1 (it) | 2005-01-04 | 2006-07-05 | Giacomo Vespasiani | Metodo e sistema per la gestione interattiva di dati relativi ad una terapia insulinica in autocontrollo per un paziente diabetico |
TWI430284B (zh) | 2005-02-22 | 2014-03-11 | Bayer Healthcare Llc | 調適成決定並儲存一分析物濃度之計量器,及標記一分析物濃度之方法 |
CN101163798A (zh) * | 2005-04-22 | 2008-04-16 | 日本化药株式会社 | 测量糖尿病患者平时和餐后高血糖症中血糖波动的1,5-脱水葡萄糖醇(1,5-ag)测定和a1c/1,5-ag测定组合 |
US7509156B2 (en) * | 2005-05-18 | 2009-03-24 | Clarian Health Partners, Inc. | System for managing glucose levels in patients with diabetes or hyperglycemia |
EP1728468A1 (de) * | 2005-06-04 | 2006-12-06 | Roche Diagnostics GmbH | Bewertung von Werten der Blutglucosekonzentration zur Einstellung der Insulindosierung |
CA2653616C (en) | 2005-06-08 | 2013-02-12 | Philip Michael Sher | Fluctuating blood glucose notification threshold profiles and methods of use |
JP2008546496A (ja) * | 2005-06-27 | 2008-12-25 | ノボ・ノルデイスク・エー/エス | ショートカットナビゲーション機能を有する送達システムのユーザインターフェース |
US20070016449A1 (en) * | 2005-06-29 | 2007-01-18 | Gary Cohen | Flexible glucose analysis using varying time report deltas and configurable glucose target ranges |
TWI417543B (zh) | 2005-08-05 | 2013-12-01 | Bayer Healthcare Llc | 具有一包含複數個預定使用者特徵位準之多重位準使用者介面之計量器及其使用方法 |
UY29721A1 (es) * | 2005-08-05 | 2007-03-30 | Bayer Healthcare Llc | Medidor con alarma de tiempo postprandial para efectuar determinaciones |
DK2260757T3 (en) | 2005-09-09 | 2016-06-27 | Hoffmann La Roche | System tools, apparatus and a program for diabetes treatment |
US8084420B2 (en) * | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
US7749371B2 (en) | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
EP1818009A1 (de) | 2006-02-11 | 2007-08-15 | Roche Diagnostics GmbH | Analysehandgerät mit Auswahl von Einstellmodi |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US8226891B2 (en) * | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US8529751B2 (en) | 2006-03-31 | 2013-09-10 | Lifescan, Inc. | Systems and methods for discriminating control solution from a physiological sample |
WO2007149533A2 (en) | 2006-06-19 | 2007-12-27 | Dose Safety | System, method and article for controlling the dispensing of insulin |
US7914460B2 (en) * | 2006-08-15 | 2011-03-29 | University Of Florida Research Foundation, Inc. | Condensate glucose analyzer |
US9056165B2 (en) * | 2006-09-06 | 2015-06-16 | Medtronic Minimed, Inc. | Intelligent therapy recommendation algorithm and method of using the same |
US20080172028A1 (en) * | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having selectable insulin absorption models |
US20080172027A1 (en) * | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having basal rate testing features |
US20080172031A1 (en) * | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having correction factors |
US20080171967A1 (en) * | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having a food database |
US20080172029A1 (en) * | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump for determining carbohydrate consumption |
US20080119702A1 (en) * | 2006-10-31 | 2008-05-22 | Abbott Diabetes Care, Inc. | Analyte meter having alert, alarm and test reminder capabilities and methods of use |
US20080119710A1 (en) * | 2006-10-31 | 2008-05-22 | Abbott Diabetes Care, Inc. | Medical devices and methods of using the same |
EP2095282A2 (en) | 2006-11-01 | 2009-09-02 | SHER, Philip Michael | Device for predicting and managing blood glucose concentration by analyzing the effect of, and controlling, pharmacodynamic insulin unit equivalents |
US8079955B2 (en) * | 2006-11-28 | 2011-12-20 | Isense Corporation | Method and apparatus for managing glucose control |
US20080139910A1 (en) * | 2006-12-06 | 2008-06-12 | Metronic Minimed, Inc. | Analyte sensor and method of using the same |
WO2008071218A1 (en) | 2006-12-14 | 2008-06-19 | Egomedical Swiss Ag | Monitoring device |
US20080154513A1 (en) * | 2006-12-21 | 2008-06-26 | University Of Virginia Patent Foundation | Systems, Methods and Computer Program Codes for Recognition of Patterns of Hyperglycemia and Hypoglycemia, Increased Glucose Variability, and Ineffective Self-Monitoring in Diabetes |
WO2008078176A1 (en) | 2006-12-22 | 2008-07-03 | Bellus Health (International) Limited | Methods, compounds, and compositions for treating metabolic disorders and diabetes |
US10154804B2 (en) * | 2007-01-31 | 2018-12-18 | Medtronic Minimed, Inc. | Model predictive method and system for controlling and supervising insulin infusion |
US20080206799A1 (en) * | 2007-02-27 | 2008-08-28 | Michael Blomquist | Carbohydrate ratio testing using frequent blood glucose input |
US8758245B2 (en) | 2007-03-20 | 2014-06-24 | Lifescan, Inc. | Systems and methods for pattern recognition in diabetes management |
US20080294024A1 (en) | 2007-05-24 | 2008-11-27 | Cosentino Daniel L | Glucose meter system and monitor |
ITMI20071098A1 (it) * | 2007-05-30 | 2008-11-30 | Santoni & C Spa | Macchina per maglieria con aghi a linguetta e senza platine di abbattitura, ad elevata affidabilita' di funzionamento. |
US20080312518A1 (en) | 2007-06-14 | 2008-12-18 | Arkal Medical, Inc | On-demand analyte monitor and method of use |
US8444595B2 (en) | 2007-06-15 | 2013-05-21 | Animas Corporation | Methods to pair a medical device and at least a remote controller for such medical device |
EP2191405B1 (en) * | 2007-06-27 | 2019-05-01 | Roche Diabetes Care GmbH | Medical diagnosis, therapy, and prognosis system for invoked events and method thereof |
EP2186035B1 (en) | 2007-06-29 | 2018-12-26 | Roche Diabetes Care GmbH | Apparatus and method for remotely controlling an ambulatory medical device |
EP2023256A1 (en) | 2007-08-02 | 2009-02-11 | Novo Nordisk A/S | Drug administration monitoring |
US20090112626A1 (en) * | 2007-10-30 | 2009-04-30 | Cary Talbot | Remote wireless monitoring, processing, and communication of patient data |
JP5427350B2 (ja) * | 2007-10-31 | 2014-02-26 | パナソニックヘルスケア株式会社 | 傾向予測装置及び傾向予測システム |
WO2009075697A1 (en) * | 2007-12-10 | 2009-06-18 | Bayer Healthcare Llc | Interface for a health measurement and monitoring system |
US9839395B2 (en) * | 2007-12-17 | 2017-12-12 | Dexcom, Inc. | Systems and methods for processing sensor data |
US20090177147A1 (en) * | 2008-01-07 | 2009-07-09 | Michael Blomquist | Insulin pump with insulin therapy coaching |
US8603768B2 (en) | 2008-01-17 | 2013-12-10 | Lifescan, Inc. | System and method for measuring an analyte in a sample |
US20090240127A1 (en) | 2008-03-20 | 2009-09-24 | Lifescan, Inc. | Methods of determining pre or post meal time slots or intervals in diabetes management |
IL197532A0 (en) | 2008-03-21 | 2009-12-24 | Lifescan Scotland Ltd | Analyte testing method and system |
US20090247982A1 (en) | 2008-03-27 | 2009-10-01 | Lifescan Inc. | Medical Device Mechanical Pump |
JP2011523478A (ja) | 2008-05-07 | 2011-08-11 | ライフスキャン・インコーポレイテッド | 検体測定及び管理デバイス、並びに関連方法 |
JP5261026B2 (ja) | 2008-05-22 | 2013-08-14 | 株式会社タニタ | 血糖値測定装置および食後平均血糖値の測定方法 |
US20100016700A1 (en) * | 2008-07-18 | 2010-01-21 | Lifescan, Inc. | Analyte measurement and management device and associated methods |
TWI377515B (en) * | 2008-08-14 | 2012-11-21 | Eps Bio Technology Corp | Health management device |
SG193205A1 (en) * | 2008-08-15 | 2013-09-30 | Lifescan Scotland Ltd | Analyte testing method and system |
US20100174228A1 (en) | 2008-10-24 | 2010-07-08 | Bruce Buckingham | Hypoglycemia prediction and control |
EP2455876A3 (en) * | 2009-06-30 | 2013-01-30 | Lifescan Scotland Limited | System and method for diabetes management |
US8487758B2 (en) * | 2009-09-02 | 2013-07-16 | Medtronic Minimed, Inc. | Medical device having an intelligent alerting scheme, and related operating methods |
CA3077994C (en) * | 2009-09-29 | 2022-06-21 | Lifescan Scotland Limited | Analyte testing method and device for diabetes management |
US20120130646A1 (en) * | 2010-11-19 | 2012-05-24 | Lifescan, Inc. | Analyte testing method and system with high and low analyte trends notification |
-
2010
- 2010-06-29 AU AU2010346623A patent/AU2010346623B2/en not_active Ceased
- 2010-06-29 CN CN201080064763.2A patent/CN102770868B/zh not_active Expired - Fee Related
- 2010-06-29 EP EP14193924.9A patent/EP2897068B1/en not_active Revoked
- 2010-06-29 EP EP13151121.4A patent/EP2590098B1/en active Active
- 2010-06-29 RU RU2012140731/08A patent/RU2553097C2/ru not_active IP Right Cessation
- 2010-06-29 ES ES10730658.1T patent/ES2532146T3/es active Active
- 2010-06-29 KR KR1020127024554A patent/KR101722417B1/ko active IP Right Grant
- 2010-06-29 WO PCT/US2010/040434 patent/WO2011106029A1/en active Application Filing
- 2010-06-29 ES ES13151120.6T patent/ES2529092T3/es active Active
- 2010-06-29 EP EP13151120.6A patent/EP2590097B1/en not_active Revoked
- 2010-06-29 JP JP2012554979A patent/JP5718947B2/ja active Active
- 2010-06-29 ES ES13151121.4T patent/ES2528705T3/es active Active
- 2010-06-29 EP EP19217470.4A patent/EP3695777A1/en active Pending
- 2010-06-29 US US12/826,543 patent/US9563743B2/en active Active
- 2010-06-29 CA CA2790910A patent/CA2790910C/en active Active
- 2010-06-29 BR BR112012021572A patent/BR112012021572A2/pt not_active Application Discontinuation
- 2010-06-29 EP EP10730658.1A patent/EP2539839B1/en active Active
-
2013
- 2013-05-22 HK HK13106063.4A patent/HK1179361A1/xx not_active IP Right Cessation
- 2013-09-26 HK HK13110993.1A patent/HK1183720A1/xx not_active IP Right Cessation
-
2016
- 2016-01-04 HK HK16100003.7A patent/HK1212068A1/xx unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008501426A (ja) * | 2004-06-03 | 2008-01-24 | メドトロニック ミニメド インコーポレイテッド | 生理的特徴のモニタリングのためのシステム |
JP2007317196A (ja) * | 2006-05-24 | 2007-12-06 | Lifescan Inc | 個別化した疾病管理を提供するためのシステム及び方法 |
JP2008229331A (ja) * | 2007-03-20 | 2008-10-02 | Lifescan Inc | 血糖症管理用の伝達媒体 |
JP2009037588A (ja) * | 2007-03-20 | 2009-02-19 | Lifescan Inc | 糖尿病の管理用プログラム |
US20110205064A1 (en) * | 2010-02-25 | 2011-08-25 | Lifescan Scotland Ltd. | Analyte testing method and system with high and low blood glucose trends notification |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2016540564A (ja) * | 2013-12-05 | 2016-12-28 | ライフスキャン・インコーポレイテッドLifescan,Inc. | 糖尿病管理用ボーラス投与フィードバック |
US10188796B2 (en) | 2013-12-05 | 2019-01-29 | Lifescan Ip Holdings, Llc | Method and system for management of diabetes with a glucose monitor and infusion pump to provide feedback on bolus dosing |
Also Published As
Publication number | Publication date |
---|---|
AU2010346623A1 (en) | 2012-09-06 |
US20110205064A1 (en) | 2011-08-25 |
BR112012021572A2 (pt) | 2016-10-25 |
EP3695777A1 (en) | 2020-08-19 |
EP2897068B1 (en) | 2020-01-01 |
RU2012140731A (ru) | 2014-03-27 |
CA2790910A1 (en) | 2011-09-01 |
CN102770868A (zh) | 2012-11-07 |
EP2590097B1 (en) | 2014-11-05 |
CN102770868B (zh) | 2017-02-22 |
HK1212068A1 (en) | 2016-06-03 |
WO2011106029A1 (en) | 2011-09-01 |
RU2553097C2 (ru) | 2015-06-10 |
KR101722417B1 (ko) | 2017-04-03 |
US9563743B2 (en) | 2017-02-07 |
ES2532146T3 (es) | 2015-03-24 |
CA2790910C (en) | 2018-10-30 |
EP2897068A1 (en) | 2015-07-22 |
KR20120123145A (ko) | 2012-11-07 |
HK1179361A1 (en) | 2013-09-27 |
JP5718947B2 (ja) | 2015-05-13 |
EP2590098A1 (en) | 2013-05-08 |
EP2590097A1 (en) | 2013-05-08 |
HK1183720A1 (en) | 2014-01-03 |
AU2010346623B2 (en) | 2015-09-03 |
ES2529092T3 (es) | 2015-02-16 |
EP2539839A1 (en) | 2013-01-02 |
EP2590098B1 (en) | 2014-11-05 |
ES2528705T3 (es) | 2015-02-11 |
EP2539839B1 (en) | 2014-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5718947B2 (ja) | 高血糖及び低血糖傾向を通知する分析物試験方法及びシステム | |
JP5744919B2 (ja) | インスリン投与の際の安全警告を備えた分析物試験方法及びシステム | |
JP5871797B2 (ja) | 糖尿病管理システム及び方法 | |
JP2014502858A (ja) | 高及び低分析物傾向通知を有する分析物試験方法及びシステム | |
US20100332445A1 (en) | Analyte testing method and system | |
US20150044650A1 (en) | Positive reinforcement messages to users based on analytics of prior physiological measurements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20130516 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20140317 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140408 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140708 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140715 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140808 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140815 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140904 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150303 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150319 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5718947 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |